Abstract
Pleomorphic adenomas occur primarily in the salivary glands, while the primary of the trachea is relatively rare. Depending on their location and size, they may elicit symptoms reminiscent of asthma and asphyxia. We performed a rigid bronchoscopic resection with a radiofrequency snare of a primary pleomorphic adenoma of the trachea with severe airway narrowing. In this case, the positive resection margins raised concerns about malignant transformation and local recurrence, but no recurrence has been observed seven years postoperatively. The low expression of Ki-67 on immunohistological examination may be one of the reasons for the absence of recurrence.
Keywords: Pleomorphic adenoma, Tracheal tumor
1. Introduction
This case report highlights a patient with primary tracheal pleomorphic adenoma who underwent successful excision via snare resection under rigid bronchoscopy. Despite positive margins, the patient has remained recurrence-free for seven years, suggesting a potential association with the tumor's Ki-67 low expression.
2. Case presentation
A 53-year-old woman was diagnosed with an asthma attack by her primary care physician and was treated with medication. However, her dyspnea worsened, so she went to the emergency department, where a chest Computed tomography (CT) (Fig. 1A) revealed severe airway narrowing due to a mass occupying approximately 90 % of the tracheal lumen.
Fig. 1.
Computed tomography (CT) shows severe tracheal obstruction due to a tumor on admission (A). CT showing no recurrence after 7 years post-resection (B).
On admission, the patient did not have a fever and had obvious wheezing on chest auscultation. A bronchoscopy was performed on the day of admission, and the flexible bronchoscope showed a smooth surface (Fig. 2A).
Fig. 2.
Flexible bronchoscopy findings at admission showed severe tumor obstruction of the main bronchus (A). Retrieved with a basket forceps after snare resection under rigid bronchoscopy (B).
During bronchoscopy, the cough reflex became stronger, and ventilation became difficult, so the patient was endotracheally intubated and managed in the intensive care unit. The patient had severe stenosis, but the tumor was considered benign, and the decision was made to perform under rigid bronchoscopic resection. Assuming the possibility of intraoperative ventilatory failure, the cardiovascular surgeon was consulted to prepare for extracorporeal membrane oxygenation (ECMO), and both patient's groins were exposed, and the femoral arteriovenous veins were marked. The patient was sedated to the extent that spontaneous breathing remained, and after resection using a rigid bronchoscope with a high-frequency snare, the patient was removed with basket forceps (Video 1, Fig. 2B).
Supplementary video related to this article can be found at https://doi.org/10.1016/j.rmcr.2024.102073
The following is the supplementary data related to this article.
1
Video 1. Rigid bronchoscopy revealed that the tumor was stalked and occupied about 90 % of the tracheal lumen. After resection with a snare, the tumor was retrieved with basket forceps.
The resection was completed without the use of ECMO. Bronchoscopy approximately 10 months later showed no recurrence at the tumor margins. Thereafter, during 7 years of outpatient follow-up, there was no recurrence (Fig. 1B).
Pathologic examination revealed localized and cordate proliferation of round, cuboidal, and polygonal cells with vitrified stroma within the tumor. Fat cells were extensively present, and a diagnosis of pleomorphic adenoma was made. In addition, there were positive margins and little or no Ki-67 labeling.
3. Discussion
Primary tracheal tumors are rare, and their frequency is reported to be approximately 1 % of lung tumors [1]. Furthermore, approximately half of the pleomorphic adenomas tend to occur in the salivary glands, especially the parotid gland, making the primary pleomorphic adenoma of the trachea a very rare entity. Literature reports of primary pleomorphic adenomas of the trachea show respiratory symptoms in many cases (Table 1). There have been reports of asthma treatment before the diagnosis of primary tracheobronchial pleomorphic adenoma, especially because of the difficulty in differential diagnosis from bronchial asthma [[2], [3], [4]]. Some cases of tracheal pleomorphic adenoma present with severe airway narrowing in more than 80 % of cases with asthma-like symptoms such as cough and dyspnea. However, the tumor may be asymptomatic because its primary location was in the left main bronchus, and it may be discovered incidentally, e.g., during the examination of other diseases [5,6]. A case with complete occlusion of the right main bronchus had only symptoms of coughing [7], but the case with complete occlusion just above the carina was accompanied by impaired consciousness.3 Primary tracheal tumors may be asymptomatic, with symptoms varying according to the site of origin, tumor size, and stenosis rate. In this study, the patient had been treated for bronchial asthma since his 30s, and his cough was diagnosed as an asthma attack. However, the patient was referred to our clinic because of dyspnea and poor response to drug therapy. Wheezing episodes refractory to drug therapy require chest CT evaluation to determine the possibility of organic stenosis. Airway stenosis may be present, and resection is the mainstay of treatment. If severe stenosis is present at the initial presentation, airway clearance is mandatory. In this case, the patient developed a severe cough following stimulation by flexible bronchoscopy performed during an initial visit to another department. Although he was in ventilatory failure, he was immediately ventilated by deepening the tracheal tube. Flexible bronchoscopy in patients with severe airway stenosis should be performed with caution. Preparation and use of ECMO should be considered to resolve ventilatory insufficiency [3], but in many cases, including ours, resection was possible without ECMO [2,[4], [5], [6], [7], [8], [9]]. Flexible bronchoscopic snare resection [5,6], APC [2,6,8], and surgical resection have been reported for tumor resection [3,4,7,9]. APC is considered useful for cauterization and hemostasis because of its shallow penetration into deep tissue. It may be useful when the tumor has no stalk and cannot be snared. We used a rigid bronchoscope for resection because of concerns about ventilation failure. Another advantage of rigid bronchoscopy is its ability to resect tumors by debulking. Pleomorphic adenomas are benign tumors that have a 3–15 % risk of malignant transformation in the distant postoperative period [10], and capsular injury during resection also increases the risk of recurrence [11,12]. Ki-67 is a protein that is released during cell division and is a marker of tumor growth. It is present during the active phase of the cell cycle and absent from resting cells [13]. Reports correlating Ki-67 expression with the prognosis of pleomorphic adenomas emphasize the importance of paying close attention to this biomarker [11,12]. The fact that patients remained recurrence-free for seven years postoperatively despite positive resection margins in our case, while most reports have a follow-up period of less than 1 year postoperatively, can be attributed to low Ki-67 expression.
Table 1.
Literature review of tracheal pleomorphic adenoma.
| Case | Author (year) | Age | Sex | Symptoms at diagnosis | History of BA | Tumor locate | Tumor size | Stenosis rate | Treatment | ECMO | Follow-up time/recurrence |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Sim et al. (2014) | 32 | F | Dyspnea | No | Trachea | 18mm | 90 % | APC under rigid BFS | No | 1 month/No |
| 2 | Casillas-Enriquez et al. (2014) | 33 | F | Wheezing, cough, hemorrhage | Yes | Trachea | NA | 80 % | APC under rigid BFS | No | 8 months/No |
| 3 | Silva et al. (2023) | 66 | M | None | No | Trachea | 12mm | NA | Sleeve resection | No | NA |
| 4 | Zhong et al. (2020) | 10 | M | Cough | No | RMB | 13mm | 100 % | Right upper lobectomy | No | 1 month/No |
| 5 | Inomata et al. (2023) | 69 | F | Dyspnea, LOC | Yes | Above the carina | 15mm | 100 % | Carina resection | Yes | 12 months/No |
| 6 | Solak et al. (2012) | 46 | F | Asthma attack | Yes | Trachea (Inside and outside of trachea) | 30mm | 90 % | Sleeve resection | No | 1 month/No |
| 7 | Goto et al. (2011) | 71 | M | None (at diagnosis with LC) | No | LMB | 25mm | 60 % | Snare resection under flexible BFS | No | Following/No |
| 8 | Matsubara et al. (2008) | 71 | M | None | No | LMB | NA | NA | Snare resection and APC under flexible BFS | No | 6 months/No |
| 9 | Current case | 54 | F | Dyspnea | Yes | Trachea | 19mm | 90 % | Snare resection under rigid BFS | No | 7 years/No |
BA: Bronchial asthma, ECMO: Extracorporeal membrane oxygenation, NA: Not available, APC: Argon plasma coagulation, BFS: Bronchofiberscopy, RMB: Right main bronchus, LOC: Loss of consciousness, LMB: Left main bronchus, LC: Lung cancer.
4. Conclusion
Primary pleomorphic adenoma of the trachea is a rare benign disease, but Ki-67 may be useful as an indicator of recurrence and possible malignant transformation.
Consent for publication
Written informed consent for publication was obtained from the patient discussed in this article.
Funding
This research did not receive any specific grant from funding agencies, commercial, or not-for-profit sectors.
CRediT authorship contribution statement
Naoya Ishibashi: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing. Toshiharu Tabata: Writing – review & editing. Ryo Nonomura: Writing – review & editing. Yutaka Oshima: Writing – review & editing. Takanobu Sasaki: Writing – review & editing. Hideki Mitomo: Writing – review & editing. Takafumi Sugawara: Writing – review & editing. Motoyasu Sagawa: Writing – review & editing. Nobuyuki Sato: Writing – review & editing.
Declaration of competing interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Handling Editor: DR AC Amit Chopra
References
- 1.Schneider P., Schirren J., Muley T., Vogt-Moykopf I. Primary tracheal tumors: experience with 14 resected patients. Eur. J. Cardio. Thorac. Surg. 2001;20(1):12–18. doi: 10.1016/s1010-7940(01)00732-1. [DOI] [PubMed] [Google Scholar]
- 2.Casillas-Enríquez J.D., Álvarez-Maldonado P., Salguero-Cruz L., Navarro-Reynoso F., Cicero-Sabido R., Núñez-Pérez Redondo C. Pleomorphic adenoma of the trachea: a case report. J Bronchology Interv Pulmonol. 2014;21(1):51–53. doi: 10.1097/LBR.0000000000000025. [DOI] [PubMed] [Google Scholar]
- 3.Inomata M., Kuroki S., Oguri N., Sato Y., Kawano F., Maeda R. Pleomorphic adenoma of the trachea: a case report. Int J Surg Case Rep. 2023;109 doi: 10.1016/j.ijscr.2023.108499. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Solak O., Ocalan K., Unlu M., Aycicek A., Aktepe F., Sivaci R. Pleomorphic adenoma of the trachea. Gen Thorac Cardiovasc Surg. 2012;60(12):843–846. doi: 10.1007/s11748-012-0081-8. [DOI] [PubMed] [Google Scholar]
- 5.Goto T., Maeshima A., Akanabe K., et al. Bronchial pleomorphic adenoma coexisting with lung cancer. Ann. Thorac. Cardiovasc. Surg. 2011;17(2):174–177. doi: 10.5761/atcs.cr.09.01516. [DOI] [PubMed] [Google Scholar]
- 6.Matsubara M., Yasuo M., Tanabe T., et al. Pleomorphic adenoma with an endobronchial resection. Intern Med. 2008;47(12):1117–1120. doi: 10.2169/internalmedicine.47.0853. [DOI] [PubMed] [Google Scholar]
- 7.Zhong H., Yan S., Jiang K., Hu Y., Dong X. A case report of bronchial pleomorphic adenoma in a child in China. BMC Pulm. Med. 2020;20(1):295. doi: 10.1186/s12890-020-01338-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Sim D.W., Oh I.J., Kim K.S., Choi Y.D., Kwon Y.S. Pleomorphic adenoma of the trachea. J Bronchology Interv Pulmonol. 2014;21(3):230–233. doi: 10.1097/LBR.0000000000000076. [DOI] [PubMed] [Google Scholar]
- 9.Silva B.S., Esteves Brandão M., Sucena M. Pleomorphic adenoma of the trachea. Arch. Bronconeumol. 2023;59(8):525. doi: 10.1016/j.arbres.2023.06.002. [DOI] [PubMed] [Google Scholar]
- 10.Lüers J.C., Wittekindt C., Streppel M., Guntinas-Lichius O. Carcinoma ex pleomorphic adenoma of the parotid gland. Study and implications for diagnostics and therapy. Acta Oncol. 2009;48(1):132–136. doi: 10.1080/02841860802183604. [DOI] [PubMed] [Google Scholar]
- 11.Choi S.Y., Choi J., Hwang I., Cho J., Ko Y.H., Jeong H.S. Comparative Longitudinal analysis of malignant transformation in pleomorphic adenoma and recurrent pleomorphic adenoma. J. Clin. Med. 2022;11(7):1808. doi: 10.3390/jcm11071808. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Liu R., Wang N., Zhang H., Ge X., Ma J.M. Clinical analysis of 109 cases of lacrimal gland pleomorphic adenoma. Int. J. Ophthalmol. 2021;14(12):1852–1857. doi: 10.18240/ijo.2021.12.07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Scholzen T., Gerdes J. The Ki-67 protein: from the known and the unknown. J. Cell. Physiol. 2000;182(3):311–322. doi: 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
1



